Effect of Induction Therapy Protocols on Transplant Outcomes in Crossmatch Positive Renal Allograft Recipients Desensitized with IVIG

This publication has 18 references indexed in Scilit:

• Intravenous Gammaglobulin (IVIG): A Novel Approach to Improve Transplant Rates and Outcomes in Highly HLA-Sensitized Patients
  American Journal of Transplantation, 2006
• A Comparison of Plasmapheresis Versus High-Dose IVIG Desensitization in Renal Allograft Recipients with High Levels of Donor Specific Alloantibody
  American Journal of Transplantation, 2006
• Antibody-mediated organ-allograft rejection
  Nature Reviews Immunology, 2005
• Current approaches to treatment of antibody‐mediated rejection
  Pediatric Transplantation, 2005
• Intravenous Immunoglobulin Induction Treatment in Flow Cytometry Cross-Match—Positive Kidney Transplant Recipients
  Human Immunology, 2005
• Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies
  The Lancet, 2005
• Evaluation of Intravenous Immunoglobulin as an Agent to Lower Allosensitization and Improve Transplantation in Highly Sensitized Adult Patients with End-Stage Renal Disease
  Journal of the American Society of Nephrology, 2004
• National Conference to Assess Antibody-Mediated Rejection in Solid Organ Transplantation
  American Journal of Transplantation, 2004
• Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients
  Transplantation, 2003
• Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients1
  Transplantation, 2003